Marked Elevation of Mature PCSK9 Levels and Inversely Decrease of Furin-cleaved PCSK9 Levels After Administration of PCSK9 Inhibitor in Patients With Acute Myocardial Infarction

被引：0
|
作者：
Nakamura, Akihiro
Kagaya, Yuta
Kanazawa, Masanori
Kondo, Masateru
Sato, Kenjiro
Endo, Hideaki
Nozaki, Eiji
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A9739
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Plasma kinetics of mature PCSK9, furin-cleaved PCSK9, and Lp(a) with or without administration of PCSK9 inhibitors in acute myocardial infarction
    Nakamura, Akihiro
    Kanazawa, Masanori
    Kagaya, Yuta
    Kondo, Masateru
    Sato, Kenjiro
    Endo, Hideaki
    Nozaki, Eiji
    JOURNAL OF CARDIOLOGY, 2020, 76 (04) : 395 - 401
  • [2] Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9
    Oleaga, Carlota
    Hay, Joshua
    Gurcan, Emma
    David, Larry L.
    Mueller, Paul A.
    Tavori, Hagai
    Shapiro, Michael D.
    Pamir, Nathalie
    Fazio, Sergio
    JOURNAL OF LIPID RESEARCH, 2021, 62
  • [3] EFFECTS OF PCSK9 VARIANTS AND PCSK9 LEVELS ON RISK OF ISCHEMIC STROKE
    Chen, W.
    Pan, Y.
    Wang, Y.
    Li, H.
    Meng, X.
    Wang, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 629 - 629
  • [4] Impact of Baseline PCSK9 Levels on the Efficacy of Evolocumab, a Monoclonal Antibody Against PCSK9
    Desai, Nihar
    Giugliano, Robert
    Wasserman, Scott
    Gibbs, John
    Liu, Thomas
    Scott, Robert
    Sabatine, Marc
    CIRCULATION, 2014, 130
  • [5] The circulating furin-cleaved/mature PCSK9 ratio has a potential prognostic significance in statin-naive patients with acute ST elevation myocardial infarction
    Sawaguchi, Jun
    Saeki, Yasuhiko
    Oda, Minako
    Takamura, Taka-aki
    Fujibayashi, Kosuke
    Wakasa, Minoru
    Akao, Hironobu
    Kitayama, Michihiko
    Kawai, Yasuyuki
    Kajinami, Kouji
    ATHEROSCLEROSIS PLUS, 2022, 50 : 50 - 56
  • [6] MEASURING PCSK9 LEVELS PRIOR TO COMMENCEMENT OF TREATMENT TO INVESTIGATE THE VARIED RESPONSE TO PCSK9 THERAPY
    Peers, K.
    Wiggins, H.
    Ramachandran, S.
    Jones, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2019, 38 : E3 - E3
  • [7] Effects of lipoprotein apheresis on PCSK9 levels
    Julius, U.
    Milton, M.
    Stoellner, D.
    Rader, D.
    Gordon, B.
    Polk, D.
    Waldmann, E.
    Parhofer, K. G.
    Moriarty, P. M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2015, 18 : 180 - 186
  • [8] Physical activity to reduce PCSK9 levels
    Tirandi, Amedeo
    Montecucco, Fabrizio
    Liberale, Luca
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [9] In Utero Base Editing of Pcsk9 Leads to Sustained Edited Cells and Reduced PCSK9 and Cholesterol Levels
    Ahn, Nicholas J.
    Stratigis, John D.
    Chadwick, Alex C.
    Coons, Barbara E.
    Hartman, Heather A.
    Rossidis, Avery C.
    Li, Haiying
    Musunuru, Kiran
    Peranteau, William H.
    MOLECULAR THERAPY, 2018, 26 (05) : 86 - 87
  • [10] Having excess levels of PCSK9 is not sufficient to induce complex formation between PCSK9 and the LDL receptor
    Wooten, Catherine J.
    Adcock, Audrey F.
    Agina-Obu, DaTonye I.
    Lopez, Dayami
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2014, 545 : 124 - 132
12345